Brett Sandercock
At a glance: Brett Sandercock is CFO at ResMed (RMD). Their latest SEC Form 4, filed Apr 3, 2026, reported a sale of $224K. On file: 0 purchase lines ($0) and 7 sale lines ($2.8M).
Disclosed holdings: about $19.8M of RMD stock: 83,495 shares reported on their latest Form 4 (filed Apr 3, 2026), valued at the Nov 19, 2026 close of $237.09. This counts only RMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CFO at Resmed Inc (RMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Brett Sandercock's InsiderPrint
7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 7 times a year, typically $254K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (7)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Megan ChungGeneral Counsel · OUST · 100% match
- Kevin Patrick McDonnellCFO · AVAV · 100% match
- Mark DorfmanEvp, Gc And Secretary · DRS · 100% match
- Lindsay Catherine LlewellynSee Remarks · LYFT · 100% match
- Michael DippoldCFO · DRS · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 3SEC | RMDResmed Inc | Sell Plan | 1,00083,495 held (−1%) | $224.31 | $224K | +5.7% |
| Mar 3SEC | RMDResmed Inc | Sell Plan | 1,00084,495 held (−1%) | $254.30 | $254K | -6.8% |
| Feb 3SEC | RMDResmed Inc | Sell Plan | 1,00085,495 held (−1%) | $257.03 | $257K | -7.8% |
| Jan 5SEC | RMDResmed Inc | Sell Plan | 1,00086,495 held (−1%) | $241.75 | $242K | -1.9% |
| Dec 2SEC | RMDResmed Inc | Sell Plan | 1,00087,495 held (−1%) | $244.16 | $244K | -2.9% |
| Nov 4SEC | RMDResmed Inc | Sell Plan | 3,00085,745 held (−3%) | $247.54 | $743K | -4.2% |
| Oct 3SEC | RMDResmed Inc | Sell Plan | 3,00086,745 held (−3%) | $274.36 | $823K | -13.6% |
- Sell
CFO Brett Sandercock sold $224K of RMD at $224.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Brett Sandercock sold $254K of RMD at $254.30 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Brett Sandercock sold $257K of RMD at $257.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Brett Sandercock sold $242K of RMD at $241.75 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Brett Sandercock sold $244K of RMD at $244.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Brett Sandercock sold $743K of RMD at $247.54 — pre-scheduled 10b5-1 plan sale.
Follow Brett Sandercock
Get one email when Brett Sandercock files a new purchase or sale. Free.
At most one email a day about Brett Sandercock, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.